Premium
P1‐124: Lithium Treatment Prevents Amyloid Toxicity and MIR‐489 Down‐Regulation in an Alzheimer’s Disease in Vitro MODEL
Author(s) -
Yamamoto Victor Junji,
Paula Vanessa de Jesus,
de Mattos Cardillo Giancarlo,
Forlenza Orestes Vicente,
Gattaz Wagner Farid,
Kerr Daniel S.
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.872
Subject(s) - viability assay , lithium (medication) , mapk/erk pathway , microrna , toxicity , biology , amyloid (mycology) , in vitro , alzheimer's disease , glial fibrillary acidic protein , microbiology and biotechnology , signal transduction , pharmacology , chemistry , medicine , disease , immunology , biochemistry , gene , endocrinology , immunohistochemistry , botany